Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab

por Sostelly, Alexandre, Mercier, François
Publicado 2019

Spectral Imaging at the Microscale and Beyond

por Paquet-Mercier, François, Greener, Jesse
Publicado 2014

Extending the Continual Reassessment Method to accommodate step‐up dosing in Phase I trials

por Braun, Thomas M., Mercier, Francois
Publicado 2022

A Model-Based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-Malignant Pain

por Mercier, François, Claret, Laurent, Prins, Klaas, Bruno, René
Publicado 2014

Single Targeted Exon Mutation Creates a True Congenic Mouse for Competitive Hematopoietic Stem Cell Transplantation: The C57BL/6-CD45.1(STEM) Mouse

por Mercier, Francois E., Sykes, David B., Scadden, David T.
Publicado 2016

A Microfluidic Bioreactor with in Situ SERS Imaging for the Study of Controlled Flow Patterns of Biofilm Precursor Materials

por Paquet-Mercier, François, Aznaveh, Nahid Babaei, Safdar, Muhammad, Greener, Jesse
Publicado 2013

Population Pharmacokinetic Analysis and Exploratory Exposure–Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A

por Retout, Sylvie, Schmitt, Christophe, Petry, Claire, Mercier, François, Frey, Nicolas
Publicado 2020

Therapeutically-induced stable disease in oncology early clinical trials

por Mercier, Francois, Meneses-Lorente, Georgina, Grimsey, Paul, Phipps, Alex, Michielin, Francesca
Publicado 2020

Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trial

por Micallef, Sandrine, Sostelly, Alexandre, Zhu, Jiawen, Baverel, Paul G., Mercier, Francois
Publicado 2022

Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII

por Jonsson, Fredrik, Schmitt, Christophe, Petry, Claire, Mercier, Francois, Frey, Nicolas, Retout, Sylvie
Publicado 2021

Identification of a Reliable Biomarker Profile for the Diagnosis of Gaucher Disease Type 1 Patients Using a Mass Spectrometry-Based Metabolomic Approach

por Menkovic, Iskren, Boutin, Michel, Alayoubi, Abdulfatah, Mercier, François E., Rivard, Georges-Étienne, Auray-Blais, Christiane
Publicado 2020

Recent Advances in Cancer Drug Discovery Through the Use of Phenotypic Reporter Systems, Connectivity Mapping, and Pooled CRISPR Screening

por Salame, Natasha, Fooks, Katharine, El-Hachem, Nehme, Bikorimana, Jean-Pierre, Mercier, François E., Rafei, Moutih
Publicado 2022

Quantitation of a Urinary Profile of Biomarkers in Gaucher Disease Type 1 Patients Using Tandem Mass Spectrometry

por Menkovic, Iskren, Boutin, Michel, Alayoubi, Abdulfatah, Curado, Filipa, Bauer, Peter, Mercier, François E., Auray-Blais, Christiane
Publicado 2022

Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer

por Morcos, Peter N., Nueesch, Eveline, Jaminion, Felix, Guerini, Elena, Hsu, Joy C., Bordogna, Walter, Balas, Bogdana, Mercier, Francois
Publicado 2018

A robust and reliable methodology to perform GECI-based multi-time point neuronal calcium imaging within mixed cultures of human iPSC-derived cortical neurons

por Patel, Niraj, Ouellet, Vincent, Paquet-Mercier, François, Chetoui, Nizar, Bélanger, Erik, Paquet, Marie-Eve, Godin, Antoine G., Marquet, Pierre
Publicado 2023

Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO

por Gibiansky, Ekaterina, Petry, Claire, Mercier, Francois, Günther, Andreas, Herman, Ann, Kappos, Ludwig, Hauser, Stephen, Yamamoto, Yumi, Wang, Qing, Model, Fabian, Kletzl, Heidemarie
Publicado 2020

Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations

por Meneses-Lorente, Georgina, Guerini, Elena, Mercier, Francois, Parrott, Neil, Kowalski, Karey, Chow-Maneval, Edna, Buchheit, Vincent, Bergthold, Guillaume, Fox, Elizabeth, Phipps, Alex, Djebli, Nassim
Publicado 2023

Characterization of the pharmacokinetics of entrectinib and its active M5 metabolite in healthy volunteers and patients with solid tumors

por Meneses-Lorente, Georgina, Bentley, Darren, Guerini, Elena, Kowalski, Karey, Chow-Maneval, Edna, Yu, Li, Brink, Andreas, Djebli, Nassim, Mercier, Francois, Buchheit, Vincent, Phipps, Alex
Publicado 2021

Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis

por Hauser, Stephen L., Bar-Or, Amit, Weber, Martin S., Kletzl, Heidemarie, Günther, Andreas, Manfrini, Marianna, Model, Fabian, Mercier, Francois, Petry, Claire, Wing, Qing, Koendgen, Harold, Smith, Terence, Kappos, Ludwig
Publicado 2023

Impact of model misspecification on model-based tests in PK studies with parallel design: real case and simulation studies

por Guhl, Mélanie, Mercier, François, Hofmann, Carsten, Sharan, Satish, Donnelly, Mark, Feng, Kairui, Sun, Wanjie, Sun, Guoying, Grosser, Stella, Zhao, Liang, Fang, Lanyan, Mentré, France, Comets, Emmanuelle, Bertrand, Julie
Publicado 2022